Significant Ownership of CITADEL ADVISORS LLC

Notable people
Ken Griffin
Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for CITADEL ADVISORS LLC focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Seth Levy - Seth Levy, Authorized Signatory
Manager location
Miami, FL

Follow Filing Activity

Follow CITADEL ADVISORS LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of CITADEL ADVISORS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BCTX BriaCell Therapeutics Corp. Common Shares, no par value per share (the "Shares") 10% $5,119,574 717,198 Kenneth Griffin 15 Jan 2026
MNTS Momentus Inc. Class A common stock, par value $0.00001 per share (the "Shares") 10% $330,612 635,792 Kenneth Griffin 15 Apr 2026
DUKR DUKE Robotics Corp. Common stock, par value $0.0001 per share (the "Shares") 10% $151,959 353,393 Kenneth Griffin 18 May 2026
FLYY Spirit Aviation Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 9.9% $14,461,405 1,624,877 Kenneth Griffin 29 Apr 2025
ASST ASSET ENTITIES INC. Class B Common Stock, par value $0.0001 per share (the "Shares") 8.1% $4,287,283 1,268,427 Kenneth Griffin 18 Aug 2025
ETHM Dynamix Corporation Class A ordinary shares, par value $0.0001 per share (the "Shares") 7.9% $13,742,566 1,312,566 Kenneth Griffin 07 Apr 2026
LXEO Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") 7.4% $40,851,767 +$1,219,315 5,498,219 +3.1% Kenneth Griffin 31 Dec 2025
SRFM SURF AIR MOBILITY INC. Common stock, par value $0.0001 per share (the "Shares") 7.1% $7,946,341 6,909,862 Kenneth Griffin 21 Apr 2026
FGNX FG Nexus Inc. Common Stock, par value $0.001 per share (the "Shares") 6.6% $61,435,465 2,501,444 Kenneth Griffin 05 Sep 2025
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") 6.5% $5,707,852 -$3,228,541 70,035 -36% Kenneth Griffin 31 Dec 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value EUR0.10 per share (the "Shares") 6.4% $78,425,733 9,194,107 Kenneth Griffin 07 Apr 2025
VENU Venu Holding Corp Common Stock, par value $0.001 per share (the "Shares") 6.4% $20,725,227 3,955,196 Kenneth Griffin 10 Mar 2026
BOLD Boundless Bio, Inc. Common stock, par value $0.0001 per share (the "Shares") 6.4% $1,763,067 1,433,388 Kenneth Griffin 26 Nov 2025
NA Nano Labs Ltd Class A ordinary shares, par value US$0.002 per share (the "Shares") 6.2% $7,347,089 -$3,916,226 1,360,572 -35% Kenneth Griffin 30 Sep 2025
JUPGD Atlas Critical Minerals Corporation Common stock, par value $0.001 per share (the "Shares") 6% $3,883,745 298,520 Kenneth Griffin 12 Jan 2026
GMRS GMR Solutions Inc. Class A common stock, par value $0.0001 per share (the "Shares") 5.9% $47,949,495 3,196,633 Kenneth Griffin 21 May 2026
LWAY LIFEWAY FOODS, INC. Common Stock, No Par Value (the "Shares") 5.8% $23,827,018 884,776 Kenneth Griffin 19 May 2026
AARD Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") 5.6% $13,635,659 1,192,971 Kenneth Griffin 14 Feb 2025
SPAI Safe Pro Group Inc. Common Stock, par value $0.0001 per share (the "Shares") 5.5% $6,960,168 -$645,499 1,200,029 -8.5% Kenneth Griffin 31 Dec 2025
HOND HCM II Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share (the "Shares") 5.4% $14,310,259 1,233,643 Kenneth Griffin 23 Sep 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 5.3% $12,405,011 980,610 Kenneth Griffin 04 Nov 2025
DPRO DRAGANFLY INC. Common shares, no par value (the "Shares") 5.3% $10,548,268 -$6,623,412 1,935,462 -39% Kenneth Griffin 31 Mar 2026
ASST Strive, Inc. Class A Common Stock, $0.001 par value per share (the "Shares") 5.2% $31,825,514 -$429,335,350 3,176,516 -93% Kenneth Griffin 31 Mar 2026
CWH Camping World Holdings, Inc. Class A Common Stock, par value $0.01 per share (the "Shares") 5.2% $23,609,874 3,334,728 Kenneth Griffin 24 Apr 2026
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") 5.1% $4,905 70,065 Kenneth Griffin 31 Mar 2026
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (the "Shares") 5% $3,711,402 +$5,414 3,042,133 +0.15% Kenneth Griffin 02 Feb 2026
QUBT Quantum Computing Inc. Common stock, par value $0.0001 per share (the "Shares") 4.9% $146,902,081 9,244,939 Kenneth Griffin 25 Sep 2025
DGHI Digi Power X Inc. Subordinate Voting Shares (the "Shares") 4.9% $5,323,196 3,550,691 Kenneth Griffin 05 May 2026
EVTL Vertical Aerospace Ltd. Ordinary Shares, par value $0.001 per share (the "Shares") 4.9% 6,255,883 Kenneth Griffin 30 Mar 2026
TARA Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 4.7% $7,031,811 1,627,734 Kenneth Griffin 31 Dec 2024
MANE Veradermics, Incorporated Common Stock, par value $0.00001 per share (the "Shares") 4.5% $128,710,490 1,870,792 Kenneth Griffin 30 Apr 2026
DFDV DeFi Development Corp. Common Stock, par value $0.00001 per share (the "Shares") 4.5% $19,964,392 1,315,654 Kenneth Griffin 14 Oct 2025
ATLX Atlas Lithium Corporation Common Stock, par value $0.001 per share (the "Shares") 4.5% $5,545,616 -$1,464,849 1,232,359 -21% Kenneth Griffin 31 Mar 2026
NB NioCorp Developments Ltd. Common Shares, without par value (the "Shares") 4.3% $27,724,925 +$25,460,182 6,216,351 +1124% Kenneth Griffin 25 Feb 2026
SLRN ACELYRIN, Inc. Common Stock, par value $0.00001 per share (the "Shares") 4.2% $10,335,933 4,218,748 Kenneth Griffin 31 Dec 2024
OPAD Offerpad Solutions Inc. Class A common stock, $0.0001 par value per share (the "Shares") 4.2% $2,346,543 1,971,885 Kenneth Griffin 13 Jan 2026
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") 4.1% $10,118,696 3,465,307 Kenneth Griffin 31 Dec 2024
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share (the "Shares") 4.1% $6,003,741 2,900,358 Kenneth Griffin 30 Sep 2025
SIDU Sidus Space Inc. Class A common stock, par value $0.0001 per share (the "Shares") 4% $7,448,193 3,210,428 Kenneth Griffin 21 Apr 2026
SPHR Sphere Entertainment Co. Class A Common Stock 3.9% $29,521,356 1,115,276 Kenneth Griffin 31 Mar 2025
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.9% $6,163,449 369,733 Citadel Advisors LLC 31 Dec 2024
LITS Lite Strategy, Inc. Common Stock, par value $0.00000002 per share (the "Shares") 3.9% $2,078,156 -$2,628,382 1,433,211 -56% Kenneth Griffin 31 Dec 2025
DBV Technologies S.A. Ordinary shares, nominal value EUR0.10 per share (the "Shares") 3.5% 8,146,510 Kenneth Griffin 31 Dec 2025
ALHC Alignment Healthcare, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.4% $117,229,222 -$66,136,407 6,718,007 -36% Kenneth Griffin 30 Sep 2025
CGEM Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") 3.4% $11,794,219 -$6,049,899 1,988,907 -34% Kenneth Griffin 30 Sep 2025
CABA Cabaletta Bio, Inc. Common stock, par value $0.00001 per share (the "Shares") 3.4% $7,371,644 -$3,903,787 3,150,275 -35% Kenneth Griffin 30 Sep 2025
DGXX DIGI POWER X INC. Subordinate Voting Shares, with no par value per share (the "Shares") 3.4% $3,474,120 1,517,083 Kenneth Griffin 10 Oct 2025
BBOT BridgeBio Oncology Therapeutics, Inc. Class A ordinary share, par value $0.0001 per share (the "Shares") 3.2% $29,391,684 2,538,142 Kenneth Griffin 30 Sep 2025
AREC American Resources Corporation Class A common stock, par value $0.0001 per share (the "Shares") 3.2% $10,633,455 -$22,121,280 3,202,848 -68% Kenneth Griffin 31 Dec 2025
UWMC UWM Holdings Corporation Class A Common Stock, par value $0.0001 per share (the "Shares") 2.8% $23,790,515 -$32,633,457 5,584,628 -58% Kenneth Griffin 30 Jun 2025
ALLO Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 2.8% $16,726,493 -$15,838,116 6,855,120 -49% Kenneth Griffin 31 Mar 2026
BKKT Bakkt Holdings, Inc. Class A Common Stock, par value $0.0001 per share (the "Shares") 2.7% $14,332,982 -$30,063,482 425,943 -68% Kenneth Griffin 30 Sep 2025
SNCY Sun Country Airlines Holdings, Inc. Common Stock, par value $0.01 per share (the "Shares") 2.5% $22,171,888 -$22,200,716 1,342,124 -50% Kenneth Griffin 31 Mar 2026
FVR FrontView REIT, Inc. Common Stock, $0.01 par value 2.4% $4,918,822 408,540 Kenneth Griffin 31 Mar 2025
ADT ADT Inc. Common stock, par value $0.01 per share (the "Shares") 2.2% $146,702,447 -$222,018,720 17,464,577 -60% Kenneth Griffin 30 Jun 2025
IMSR TERRESTRIAL ENERGY INC. Common stock, par value $0.0001 per share (the "Shares") 2.2% $24,811,883 2,303,796 Kenneth Griffin 31 Dec 2025
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 2% $1,776,097 1,409,601 Kenneth Griffin 31 Mar 2025
INSP Inspire Medical Systems, Inc. Common Stock, par value $0.001 per share (the "Shares") 1.8% $50,085,615 -$112,653,375 527,217 -69% Kenneth Griffin 31 Dec 2025
CMPS COMPASS Pathways plc Ordinary Shares, par value of GBP 0.008 per share (the "Shares"), each represented by one American Depositary Share 1.7% $4,397,992 1,166,576 Kenneth Griffin 31 Dec 2024
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (the "Shares") 1.7% $700,612 223,125 Kenneth Griffin 31 Dec 2025
ATCX Atlas Critical Minerals Corporation Common stock, par value $0.001 per share (the "Shares") 0.9% 43,834 Kenneth Griffin 31 Mar 2026
ARVN ARVINAS, INC. Common stock, par value $0.001 per share (the "Shares") 0.4% $2,251,350 -$27,399,315 264,243 -92% Kenneth Griffin 30 Sep 2025
ALTS ALT5 Sigma Corporation Common Stock, par value $0.001 per share (the "Shares") 0.2% $1,760,642 282,607 Kenneth Griffin 12 Aug 2025
VYNE VYNE Therapeutics Inc. Common Stock, par value $0.0001 (the "Shares") 0% $1,250 -$367,360 3,732 -100% Kenneth Griffin 30 Sep 2025
RZLV Rezolve AI plc Ordinary Shares, par value (GBP)0.0001 per share (the "Shares") 0% $0 -$57,014,164 0 -100% Citadel Advisors LLC 31 Dec 2025
HE HAWAIIAN ELECTRIC INDUSTRIES INC Common Stock, Without Par Value (the "Shares") 0% $0 0 Citadel Advisors LLC 31 Dec 2024
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 0% $0 0 Citadel Advisors LLC 31 Dec 2024
CBNA Chain Bridge Bancorp, Inc. Class A common stock, par value $0.01 per share 0% $0 0 Citadel Advisors LLC 31 Mar 2025
ACRV Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 0% $0 -$2,772,206 0 -100% Citadel Advisors LLC 31 Mar 2026

Schedules 13D/G Reported by CITADEL ADVISORS LLC:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .